+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Nucleic Acid Amplification Test"

From
The Worldwide Market for In Vitro Diagnostic Tests, 16th Edition - Product Thumbnail Image

The Worldwide Market for In Vitro Diagnostic Tests, 16th Edition

  • Report
  • August 2023
  • 1500 Pages
  • Global
From
Blood Transfusion Diagnostics Global Market Report 2024 - Product Thumbnail Image

Blood Transfusion Diagnostics Global Market Report 2024

  • Report
  • February 2024
  • 250 Pages
  • Global
From
From
From
From
Loading Indicator

The Nucleic Acid Amplification Test (NAAT) market is a segment of the In Vitro Diagnostics (IVD) industry. NAATs are used to detect and quantify nucleic acids, such as DNA and RNA, from a variety of sources. These tests are used to diagnose and monitor a wide range of infectious diseases, including HIV, hepatitis, and tuberculosis. NAATs are also used to detect genetic mutations associated with cancer and other inherited diseases. NAATs are highly sensitive and specific, and can be used to detect very small amounts of nucleic acid. This makes them ideal for use in clinical settings, where rapid and accurate diagnosis is essential. NAATs are also used in research and public health settings, where they can be used to monitor the spread of infectious diseases. The NAAT market is highly competitive, with many companies offering a range of products. Some of the major players in the market include Roche Diagnostics, Abbott Laboratories, Becton Dickinson, Cepheid, and Hologic. Show Less Read more